BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30885440)

  • 1. Intelligence decline between present and premorbid IQ in schizophrenia: Schizophrenia Non-Affected Relative Project (SNARP).
    Ohi K; Shimada T; Kataoka Y; Koide Y; Yasuyama T; Uehara T; Okubo H; Kawasaki Y
    Eur Neuropsychopharmacol; 2019 May; 29(5):653-661. PubMed ID: 30885440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia.
    Ohi K; Takai K; Sugiyama S; Kitagawa H; Kataoka Y; Soda M; Kitaichi K; Kawasaki Y; Ito M; Shioiri T
    CNS Spectr; 2021 Mar; ():1-7. PubMed ID: 33731244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects.
    Ohi K; Nishizawa D; Sugiyama S; Takai K; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
    Int J Neuropsychopharmacol; 2021 Jul; 24(7):562-569. PubMed ID: 33738471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetric complications and intelligence in patients on the schizophrenia-bipolar spectrum and healthy participants.
    Wortinger LA; Engen K; Barth C; Lonning V; Jørgensen KN; Andreassen OA; Haukvik UK; Vaskinn A; Ueland T; Agartz I
    Psychol Med; 2020 Aug; 50(11):1914-1922. PubMed ID: 31456537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient.
    Ohi K; Sumiyoshi C; Fujino H; Yasuda Y; Yamamori H; Fujimoto M; Sumiyoshi T; Hashimoto R
    Front Psychiatry; 2017; 8():293. PubMed ID: 29312019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.
    Vreeker A; Boks MP; Abramovic L; Verkooijen S; van Bergen AH; Hillegers MH; Spijker AT; Hoencamp E; Regeer EJ; Riemersma-Van der Lek RF; Stevens AW; Schulte PF; Vonk R; Hoekstra R; van Beveren NJ; Kupka RW; Brouwer RM; Bearden CE; MacCabe JH; Ophoff RA;
    Psychol Med; 2016 Mar; 46(4):807-18. PubMed ID: 26621616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.
    Weickert TW; Goldberg TE; Gold JM; Bigelow LB; Egan MF; Weinberger DR
    Arch Gen Psychiatry; 2000 Sep; 57(9):907-13. PubMed ID: 10986554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia.
    Khandaker GM; Barnett JH; White IR; Jones PB
    Schizophr Res; 2011 Nov; 132(2-3):220-7. PubMed ID: 21764562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior intellectual ability in schizophrenia: neuropsychological characteristics.
    MacCabe JH; Brébion G; Reichenberg A; Ganguly T; McKenna PJ; Murray RM; David AS
    Neuropsychology; 2012 Mar; 26(2):181-90. PubMed ID: 22201301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: a 10-year follow-up study.
    van Winkel R; Myin-Germeys I; Delespaul P; Peuskens J; De Hert M; van Os J
    Schizophr Res; 2006 Dec; 88(1-3):47-54. PubMed ID: 16904292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Subtypes of Schizophrenia Characterized by Differential Brain Volumetric Reductions and Cognitive Decline.
    Weinberg D; Lenroot R; Jacomb I; Allen K; Bruggemann J; Wells R; Balzan R; Liu D; Galletly C; Catts SV; Weickert CS; Weickert TW
    JAMA Psychiatry; 2016 Dec; 73(12):1251-1259. PubMed ID: 27829096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimensions of intelligence in schizophrenia: evidence from patients with preserved, deteriorated and compromised intellect.
    Badcock JC; Dragović M; Waters FA; Jablensky A
    J Psychiatr Res; 2005 Jan; 39(1):11-9. PubMed ID: 15504419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved, deteriorated, and premorbidly impaired patterns of intellectual ability in schizophrenia.
    Ammari N; Heinrichs RW; Pinnock F; Miles AA; Muharib E; McDermid Vaz S
    Neuropsychology; 2014 May; 28(3):353-8. PubMed ID: 24635707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated cognitive decline in patients with schizophrenia: A multicenter study.
    Fujino H; Sumiyoshi C; Yasuda Y; Yamamori H; Fujimoto M; Fukunaga M; Miura K; Takebayashi Y; Okada N; Isomura S; Kawano N; Toyomaki A; Kuga H; Isobe M; Oya K; Okahisa Y; Takaki M; Hashimoto N; Kato M; Onitsuka T; Ueno T; Ohnuma T; Kasai K; Ozaki N; Sumiyoshi T; Imura O; Hashimoto R;
    Psychiatry Clin Neurosci; 2017 May; 71(5):294-300. PubMed ID: 27804186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in executive function among patients with schizophrenia, their unaffected first-degree relatives and healthy participants.
    Kataoka Y; Shimada T; Koide Y; Okubo H; Uehara T; Shioiri T; Kawasaki Y; Ohi K
    Int J Neuropsychopharmacol; 2020 Jul; 23(11):731-7. PubMed ID: 32692837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive heterogeneity in first-episode schizophrenia.
    Joyce EM; Hutton SB; Mutsatsa SH; Barnes TR
    Br J Psychiatry; 2005 Dec; 187():516-22. PubMed ID: 16319403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
    Ohi K; Nishizawa D; Sugiyama S; Takai K; Fujikane D; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
    Psychol Med; 2023 Jul; 53(10):4454-4463. PubMed ID: 35971752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premorbid IQ in patients with functional psychosis and their first-degree relatives.
    Gilvarry C; Takei N; Russell A; Rushe T; Hemsley D; Murray RM
    Schizophr Res; 2000 Feb; 41(3):417-29. PubMed ID: 10728719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways to functional outcomes in schizophrenia: the role of premorbid functioning, negative symptoms and intelligence.
    Brill N; Levine SZ; Reichenberg A; Lubin G; Weiser M; Rabinowitz J
    Schizophr Res; 2009 May; 110(1-3):40-6. PubMed ID: 19297133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal/executive impairments in schizophrenia.
    Morice R; Delahunty A
    Schizophr Bull; 1996; 22(1):125-37. PubMed ID: 8685655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.